Shuwei Liu, MD
Family Medicine · Manchester, NHNPI 1770563058
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 96 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 23 manufacturers, the largest accounting for just 11.6% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,343 and has fallen 97.0% since, to $40 in 2021.
Across 96 payments — averaging $17.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$193
- Takeda Pharmaceuticals U.S.A., Inc.$154
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$147
- GSK$122
- AstraZeneca$121
- AbbVie$116
- plus $812 from 17 others
What the payments were for
- Food & beverage$1,665100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen(2 entities) | 10 | $193 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $154 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 8 | $147 |
| GSK | 7 | $122 |
| AstraZeneca | 8 | $121 |
| AbbVie(2 entities) | 6 | $116 |
| Novo Nordisk | 7 | $104 |
| Merck | 7 | $104 |
| Vifor Pharma, Inc. | 1 | $95 |
| Boehringer Ingelheim | 4 | $81 |
| Antares Pharma, Inc. | 4 | $76 |
| Lilly USA, LLC | 6 | $76 |
| Pfizer | 4 | $55 |
| Johnson & Johnson | 3 | $43 |
| Astellas Pharma US Inc | 2 | $37 |
| Radius Health, Inc. | 2 | $29 |
| Hologic Sales And Service, LLC | 1 | $22 |
| Novartis | 1 | $20 |
| Otsuka America Pharmaceutical, Inc. | 1 | $17 |
| Ironshore Pharmaceuticals Inc. | 1 | $15 |
| Avion Pharmaceuticals | 1 | $14 |
| Sanofi Pasteur Inc. | 1 | $14 |
| Teva Pharmaceuticals USA, Inc. | 1 | $11 |
How this compares
$1,665 in reported general payments places this provider in the 85th percentile of 397 family medicine providers in New Hampshire.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 14 | $25,123 |
| TrulicityDulaglutide | 14 | $24,666 |
| EliquisApixaban | 15 | $17,584 |
| JardianceEmpagliflozin | 13 | $14,970 |
| Arnuity ElliptaFluticasone Furoate | 12 | $3,389 |
| Rosuvastatin Calcium | 57 | $1,983 |
| Atorvastatin Calcium | 186 | $1,587 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 47 | $1,179 |
| Metoprolol Succinate | 90 | $1,147 |
| Levothyroxine Sodium | 97 | $946 |
| Omeprazole | 65 | $942 |
| Ezetimibe | 31 | $887 |
| Amlodipine Besylate | 153 | $873 |
| Duloxetine Hcl | 16 | $829 |
| SynthroidLevothyroxine Sodium | 15 | $692 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $104 | $25,12314 claims |
| Lilly USA, LLCTrulicity | $76 | $24,66614 claims |
| PfizerEliquis | $55 | $17,58415 claims |
| Boehringer IngelheimJardiance | $81 | $14,97013 claims |
| GSKArnuity Ellipta | $122 | $3,38912 claims |
| AbbVieSynthroid | $116 | $69215 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 397 family medicine providers in New Hampshire.
Other family medicine in Manchester
- Mark TimmermanManchester$4K
- Mark BallentynePortsmouth$135K
- M LauterPortsmouth$21K
- Brian SponsellerNorth Conway$15K
- Cecilia Vicuna KeadyCharlestown$13K
- Keenan Al-HojerryPortsmouth$11K
- Peter LoeserConcord$10K
- Robyn StewartDerry$8K
- Robert KellyExeter$8K
- Dennis BadmanSanbornville$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.